{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T20:48:29Z","timestamp":1648932509598},"reference-count":0,"publisher":"Ecancer Global Foundation","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3332\/ecancer.2011.220","type":"journal","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T14:54:50Z","timestamp":1481208890000},"source":"Crossref","is-referenced-by-count":1,"title":["ecancermedicalscience"],"prefix":"10.3332","member":"1871","container-title":[],"original-title":[],"link":[{"URL":"http:\/\/ecancer.org\/journal\/5\/pdf\/220-management-of-dermatologic-toxicities-related-to-epidermal-growth-factor-receptor-inhibitor-therapy-across-europe-can-we-get-a-consensus.php","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T14:54:50Z","timestamp":1481208890000},"score":1,"resource":{"primary":{"URL":"http:\/\/ecancer.org\/ecms\/5\/220"}},"subtitle":[],"short-title":["ecancer"],"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3332\/ecancer.2011.220","relation":{},"ISSN":["1754-6605"],"issn-type":[{"value":"1754-6605","type":"electronic"}],"subject":[]}}